Abstract
Increased global research is focused on the development of novel therapeutics to combat antimicrobial and antiviral resistance. Pistachio nuts represent a good source of protein, fiber, monounsaturated fatty acids, minerals, vitamins, and phytochemicals (carotenoids, phenolic acids, flavonoids and anthocyanins). The phytochemicals found in pistachios are structurally diverse compounds with antimicrobial and antiviral potential, demonstrated as individual compounds, extracts and complexed into nanoparticles. Synergistic effects have also been reported in combination with existing drugs. Here we report an overview of the antimicrobial and antiviral potential of pistachio nuts: studies show that Gram-positive bacterial strains, such as Staphylococcus aureus, are the most susceptible amongst bacteria, whereas antiviral effect has been reported against herpes simplex virus 1 (HSV-1). Amongst the known pistachio compounds, zeaxanthin has been shown to affect both HSV-1 attachment penetration of human cells and viral DNA synthesis. These data suggest that pistachio extracts and derivatives could be used for the topical treatment of S. aureus skin infections and ocular herpes infections.
1 Introduction
Tackling antimicrobial resistance (AMR), considered a threat to global human health, is a key research priority. The term ‘antimicrobial’ includes antibiotic, antiprotozoal, antiviral and antifungal medicines. AMR causes an estimated death of at least 1.27 million people worldwide and was associated with nearly 5 million deaths in 2019, according to a recent report released in The Lancet (Murray et al., 2022). In the U.S., more than 2.8 million antimicrobial-resistant infections occur each year, resulting in the death of more than 35,000 people (CDC, 2019). The estimated national cost in the U.S. to treat infections caused by multidrug-resistant pathogens frequently found in hospital environments can be substantial, leading to more than $4.6 billion annually. Dedicated prevention and infection control efforts can reduce the impact of antimicrobial-resistant infections, lowering deaths by an average of 18% (and by nearly 30% in hospitals in the U.S. in 2019). However, the COVID-19 pandemic has harmed recent AMR prevention and control. Therefore, the United Nations and the World Health Organization are leading initiatives to raise awareness of the problem and deliver solutions to protect our ability to fight infectious diseases globally. Therefore, the discovery of novel therapeutics with antimicrobial and antiviral effects, to be used either alone or in combination with existing drugs, is warranted.
It is well known that plant extracts represent an important source of bioactive compounds, mainly secondary metabolites, which could be used for their antimicrobial and antiviral potential. Tree nuts are known to contain an array of phytochemicals with potential health benefits (Gervasi et al., 2021). However, the phytochemical content of tree nuts can vary considerably, and depends on nut species, genotype, pre- and post-harvest conditions, and storage conditions (Bolling et al., 2011). Additionally, processing approaches such as roasting, may affect tree nut phytochemicals. For example, the total phenol content and the ferric-reducing antioxidant power (FRAP) value both decreased in almond skins after roasting, although the flavonoids concentration was not affected (Bolling et al., 2010a). The choice of solvents used for polyphenols and phytosterols extraction also significantly affects their quantification, and biological activity (Ghırardello et al., 2010). Qasimi et al. (2016) tested the effect of five different solvents (water, 80% methanol, 80% ethanol, acetone and chloroform) on the polyphenols and proanthocyanidin quantification as well as the biological potential [total phenolic (TPC), total flavonoid (TFC, antioxidant capacity using DPPH radical scavenging and ferric reducing antioxidant power (FRAP) activities] of medicinal alophytes: results showed that 80% methanol was the most effective solvent, followed by ethanol and water. Pistachio (Pistacia vera L.) nuts represent a good source of protein, fiber, monounsaturated fatty acids, minerals, and vitamins, as well as carotenoids, phenolic acids, flavonoids and anthocyanins (Mandalari et al., 2021). The phytochemical fraction in pistachios is known to contribute to their antimicrobial and antiviral effect and could help overcome AMR (Mandalari et al., 2021).
Here, we present an overview of the antimicrobial and antiviral potential of pistachio nuts. In addition, the evaluation of pistachio polyphenols, alone or in combination with existing drugs, is described in this review in an attempt to provide novel tools to combat AMR.
2 Antimicrobial and antiviral properties of pistachio bioactives
Pistachios are known to contain an array of bioactive compounds, which include carotenoids1 [beta-carotene, alpha-carotene, lutein and zeaxanthin, chlorophylls (chlorophyll a, chlorophyll b, pheaphytin a)] (Giuffrida et al., 2006; Bellomo and Fallico, 2007), gamma-tocopherol, gamma-tocotrienol, phytosterols1 (campsterol, beta-sitosterol, stigmasterol), phenolic acids1,2 (Neveu et al., 2010), resveratrol (Tokuşoglu et al., 2005; Gentile et al., 2007; Grippi et al., 2008), flavonoids1,2 (Tomaino et al., 2010), anthocyanins (cyanidin-3-galactoside, cyanidin-3-glucoside) (Seeram et al., 2008), proanthocyanidins (PAC) and stilbenes1,3, isoflavones (genistein, genistein-7-O-glucoside, dadzein) (Bulló et al., 2015), as well as phytates, sphingolipids, alkylphenols and lignans (Bolling et al., 2010b). The total phenolic content (TPC, mg gallic acid equivalent/100 g, fresh weight) in pistachios has been reported to between 1657 (USDA) and 1,420 (Phenol-Explorer), where the most abundant phenolic compounds were: daidzein, genistein, quercetin, eriodictyol, luteolin, naringenin, and cyanidins (amongst flavonoids); gallic acid and derivatives including gallotannins; alkyl phenols4,5 (anacardic acid derivatives) (Yang et al., 2009).
Current research shows the principal health-related properties of bioactive compounds found in pistachios including their antioxidant and cytoprotective effects, their effect on cell redox homeostasis, as well as their anti-inflammatory and anti-cancer effects, neuroprotective, anti-obesity and anti-diabetic effects (Maestri, 2023). Additionally, a growing body of research has documented antimicrobial and antiviral properties associated with numerous pistachio compounds, as reported in Table 1 (carotenoids, chlorophylls, gamma tocopherol, phytosterols and resveratrol) and Table 2 (flavonoids, isoflavones, anthocyanins and proanthocyanidins). Here, we discuss the antimicrobial and antiviral properties of each of these classes of compounds in more detail.
Table 1
| Compound | Antimicrobial effect | Active antimicrobial concentration | Antiviral effect | Active antiviral concentration | Reference |
|---|---|---|---|---|---|
| Beta-carotene | Klebsiella pneumonia, Escherichia coli, Staphylococcus aureus Salmonella enteritidis | 100 mg/mL 3.8 log units | Abdulhadi et al. (2020) Hayashi et al. (2012) | ||
| Lutein | Enterococcus faecium, Staphylococcus saprophyticus, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae | 8.0–256.0 μg/mL | Hepatitis B | 40 μg/mL | Mitra et al. (2021) Pang et al. (2010) |
| Zeaxanthin | Herpes simplex virus 1 | 10 μg/mL | Pennisi et al. (2023) | ||
| Chlorophylls | Gram-positive and Gram-negative bacteria | Photosensitizing effect | SARS-CoV-2 | > 65 nM | Bertoloni et al. (1992), Jimenez-Aleman et al. (2021) |
| Gamma tocopherol | Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, Staphylococcus aureus, Chromobacterium violaceum Erwinia carotovora | 0.25–2.0% (v/v) | Ulusoy et al., 2009 | ||
| Campesterol | Staphylococcus aureus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae | 0.4–1.3 mM | Herpes simplex virus 2 | 300 μg/mL | Freitas da Silva et al. (2023) Alqurashi et al. (2022) Jamhour et al. (2022) |
| SARS-CoV-2 | - | ||||
| Beta-sitosterol | Vibrio species Staphylococcus aureus | 10 μg/mL 10 μg/mL | Herpes simplex virus 2 | 2.7 μg/mL | Ravi et al. (2020) Toujani et al. (2018), Alqurashi et al. (2022) |
| Stigmasterol | S. typhi K.pneumoniae Candida albicans Candida krusei | 100 μg/mL 12.5–50.0 μg/mL | Herpes simplex virus 2 | 5 μM and 10 μM | Petrera et al., 2014 Yusuf et al. (2018) Jamhour et al. (2022) Djouonzo et al. (2023) |
| SARS-CoV-2 | 36.45 μg/mL | ||||
| Resveratrol | Gram-positive and Gram-negative bacteria, Fungi | 25.0–128.0 μg/mL 10.0–50.0 μg/mL | Influenza virus | 10–20 μg/mL | Abedini et al. (2021) |
| Rhinovirus | 10–50 μM | ||||
| Respiratory syncytial virus | 30 mg/kg body weight | ||||
| Coronavirus | 62.5 μM |
Antimicrobial and antiviral effects of pistachio carotenoids, chlorophylls, gamma tocopherol, phytosterols and resveratrol.
Table 2
| Compound | Antimicrobial effect | Active antimicrobial concentration | Antiviral effect | Active antiviral concentration | Reference |
|---|---|---|---|---|---|
| Catechin | Escherichia coli, Salmonella sp., Staphylococcus aureus | 6–50 mg/mL 0.15 mg/mL | Herpes simplex virus 1 | 0.4 mg/mL | Ma et al. (2019) Musarra-Pizzo et al. (2019) |
| Epicatechin | Staphylococcus aureus, Helicobacter pylori | 0.078–0.15 mg/mL 128–1,024 μg/mL | Herpes simplex virus 1 | 0.4 mg/mL | Taylor et al. (2005) Reygaert (2014)Musarra-Pizzo et al. (2019) Bisignano et al. (2013b) |
| Quercetin | Gram-positive and Gram-negative bacteria Fungi | 0.002–8 mg/mL 16–64 μM | Flaviviridae | 50 μM | Rojas et al. (2016) Anand David et al. (2016)Nguyen and Bhattacharya, (2022) Di Petrillo et al. (2022) Fanunza et al. (2020) |
| Orthomyxoviridae | 1.2 μM | ||||
| Herpesviridae | 145 μM | ||||
| Coronaviridae | 200 μM | ||||
| Retroviridae | 11.0 μM | ||||
| Enterovirus 71 (EV71) | 39.63 μg/mL | ||||
| Coxsackievirus A16 (CVA16) | 59.53 μg/mL | ||||
| Filoviridae | 7.4 μM | ||||
| Eriodictyol | Escherichia coli, Salmonella enterica, Pseudomonas putida, Bacillus subtilis, Listeria innocua, Lactococcus lactis, Staphylococcus aureus, Saccharomyces cerevisiae | 250–800 μg/mL | SARS-CoV-2 | 10 μM | Mandalari et al. (2007), Kaul et al. (2021) |
| Naringenin | Staphylococcus aureus, Listeria monocytogenes, Salmonella enterica | 250–500 μg/mL | SARS-CoV-2 | 200 μM | Mandalari et al. (2010), Kaul et al. (2021) |
| Kaempferol | Gram-positive and Gram-negative bacteria Fungi | 0.5-625 μg/mL 25-500 μg/mL | SARS-CoV-2 | 200 μM | Periferakis et al. (2022), Kaul et al. (2021) |
| Apigenin | Gram-positive and Gram-negative bacteria Fungi | Herpes simplex virus 1 | 5 μg/mL | Wang et al. (2019) Lee et al. (2023) Kaul et al. (2021) | |
| Enterovirus 71 | 11.0 μM | ||||
| 2–400 μg/mL | Hepatitis C virus | 0.1 μM- 5 μM | |||
| 8–68 μg/mL | Dengue virus | 40 μM | |||
| SARS-CoV-2 | 200 μM | ||||
| Influenza virus | 1.438 μg/mL- 15.3 μg/mL | ||||
| Luteolin | Staphylococcus aureus Listeria monocytogenes | Coronavirus | 10.6 μM | Yi et al. (2004) Xu et al. (2014) Qian et al. (2020) Banerjee et al. (2022) Lu et al. (2023) Wang et al. (2023) Wang et al. (2020) | |
| 16–32 μg/mL | Influenza virus | 73 ± 3 nM | |||
| 32–64 μg/mL | Enterovirus 71 | 10.31 μM | |||
| Rotavirus | 2.79–4.36 mM | ||||
| Herpes virus | 25 μM | ||||
| Respiratory syncytial virus | 2.075–49.94 μM | ||||
| Genistein | Staphylococcus aureus, Bacillus cereus | 62.5–1,000 μM | Herpes B virus | 33 μM | Hong et al. (2006) LeCher et al. (2019) Vela et al. (2010) |
| Hemorrhagic fever virus | 50 μM - 100 μM | ||||
| Daidzein | Staphylococcus aureus (ATCC and clinical isolates) | 2,048–4,096 μg/mL | Hepatitis C virus | 50 μM | Lalouckova et al. (2021) He et al. (2021) |
| Anthocyanins | Escherichia coli, Salmonella sp. Staphylococcus aureus, Listeria monocytogenes | Herpes simplex virus 1 | > 20 μg/mL | Choudhary and Pan (2020) Ma et al. (2019)El Majdoub et al. (2021), Mohammadi Pour et al. (2019) Hayashi et al. (2003) | |
| 10–400 mg/mL | Coxsackievirus B1 | – | |||
| Influenza A virus | 48 mug/ml | ||||
| Influenza B virus | 54 mug/ml | ||||
| Avian influenza virus | – |
Antimicrobial and antiviral effects of pistachio flavonoids, isoflavones, anthocyanins and proanthocyanidins.
2.1 Carotenoids
Carotenoids are tetraterpene pigments which exhibit orange, yellow, red and purple colours. Amongst the carotenoids present in pistachio nuts, β-carotene at a concentration of 100 mg/mL showed the best antimicrobial activity against the bacterial species Klebsiella pneumoniae (inhibition zone diameter of 40 mm), followed by Escherichia coli and Staphylococcus aureus (inhibition zone diameter of 36 and 31 mm, respectively, Abdulhadi et al. (2020)). However, no effect was shown against Pseudomonas aeruginosa. In addition, β -carotene has been found to induce an increase from 1.4 to 3.8 log units in the bactericidal activity of a bovine lactoperoxidase system, evaluated using Salmonella enteritidis (Hayashi et al., 2012).
According to Mitra et al. (2021), the carotenoid pigment lutein was able to inhibit both the growth and the proliferation of several Gram-positive and Gram-negative bacteria, such as Enterococcus faecium, S. saprophyticus, S. aureus, E. coli, P. aeruginosa, K. pneumoniae, at concentrations varying from 8 to 256 μg/mL. The in vitro antiviral activity of lutein against the hepatitis B virus (HBV) has been reported by Pang et al. (2010). The antiviral functions of lutein have also been investigated in stable HBV-producing human hepatoblastoma HepG2 2.2.15 cells, where it efficiently suppressed the dose-dependent secretion of HBsAg and inhibited extracellular HBV DNA. We have recently reported that zeaxanthin, a dietary carotenoid that accumulates in the retina as a macular pigment, exhibits strong antiviral activity against herpes simplex virus 1 (HSV-1, CC50: 16.1 μM, EC50 4.08 μM, SI 3.96), affecting viral attachment and penetration as well as viral DNA synthesis (Pennisi et al., 2023). An overview of the use of carotenoids as therapeutic strategies against emerging viral diseases, such as COVID-19, has recently been published (Khalil et al., 2021). The inhibitory activity of two marine carotenoids blocking the entry of SARS-CoV-2 has also been reported (Yim et al., 2021).
2.2 Tocopherols
Tocopherols are a class of organic fat-soluble phenolic compounds, many of which have vitamin E activity. The antibacterial potential of gamma-tocopherol has been demonstrated in flower extracts of Damask rose (Rosa damascena Mill), which contained beta-carotene, alpha-tocopherol and phenolic compounds as well as gamma-tocopherol: results demonstrated a strong antibacterial activity against E. coli (ATCC 25922), P. aeruginosa (ATCC 27853), Bacillus subtilis (ATCC 6633), S. aureus (ATCC 6538), Chromobacterium violaceum (ATCC 12472) and Erwinia carotovora (ATCC 39048) strains (Ulusoy et al., 2009).
2.3 Chlorophylls
The susceptibility of Gram-positive and Gram-negative bacteria to photodynamic therapy using natural chlorophylls, the green photosynthetic pigments found in plants, has been widely investigated (Bertoloni et al., 1992; Merchat et al., 1996; Minnock et al., 1996). The use of derivatives of natural chlorophylls as agents for antimicrobial photodynamic therapy has recently been reviewed also in relation to their effect against bacterial biofilm, which is known to be highly resistant to antibiotic treatment (Suvorov et al., 2021). A chlorophyll derivative pheophorbide A (PheoA), a porphyrin compound similar to animal Protoporphyrin IX, has shown an antiviral activity against SARS-CoV-2, preventing infection of cultured monkey and human cells, without noticeable cytotoxicity (Jimenez-Aleman et al., 2021).
2.4 Phytosterols
Phytosterols are plant-based compounds similar to cholesterol. Using the microdilution method, the phytosterol campsterol displayed a weak antibacterial effect in vitro against S. aureus (ATCC 6538), Streptococcus mutans (ATCC 0046), E. coli (ATCC 10536), P. aeruginosa (ATCC 15442), and K. pneumoniae (ATCC 10031), with minimum inhibitory concentration (MIC) values of 1.280 mM (Freitas da Silva et al., 2023). Through computational analyses, it was proposed that β-sitosterol exhibited antibacterial activity against several bacterial Vibrio species and could be used in aquaculture, both as a nutritional supplement and also as a disease control agent to prevent and control fish diseases caused by bacterial infection (Ravi et al., 2020). Furthermore, β-sitosterol isolated from the leaves of the South American firespike plant (Odontonema strictum) has been found to be active against S. aureus, showing both a bacteriostatic and a bactericidal effect (Pierre Luhata and Usuki, 2021). Yusuf et al. (2018) have demonstrated the antibacterial and the antifungal activity of stigmasterol isolated from the stem bark of the African tree species Neocarya macrophylla (Yusuf et al., 2018).
Seed oil from the prickly pear (Opuntia ficus-indica) containing phytosterols, primarily campesterol, followed by γ- & β -sitosterol, and stigmasterol, has been shown to exhibit an antiviral effect (22.67 ± 2.79%) at 300 μg/mL of oil against herpes simplex type 2 (HSV-2) virus (Alqurashi et al., 2022). After rutin, stigmasterol and campesterol were shown to be the most prominent inhibitors for SARS-CoV-2 proteins using an in-silico approach (Jamhour et al., 2022).
2.5 Resveratrol
Resveratrol is a natural phenolic compound with antioxidant-like properties. A comprehensive study on the antimicrobial and antiviral properties of resveratrol as an alternative therapy has recently been published by Abedini et al. (2021) (Abedini et al., 2021). Resveratrol has been shown to inhibit the growth of numerous bacteria detrimental to human health, including B. cereus species (at a concentration of 50 μg/mL) (Paulo et al., 2010), Mycobacterium smegmatis (64 μg/mL) (Lechner et al., 2008), Helicobacter pylori (25–50 μg/mL) (Makobongo et al., 2014), Vibrio cholerae (60 μg/mL) (Augustine et al., 2014), Neisseria gonorrhoeae (75 μg/mL) (Vestergaard and Ingmer, 2019), Campylobacter coli (50 μg/mL) (Duarte et al., 2015), and Arcobacter cryaerophilus (50 μg/mL) (Ferreira et al., 2014). An antifungal activity of resveratrol has been reported in vitro against the yeast Candida albicans at a concentration of 20 μg/mL (Lee and Lee, 2015). Furthermore, resveratrol has been shown to have inhibitory activity against viral replication and viral-induced inflammation by several respiratory viruses, including influenza virus (Pourghanbari et al., 2016), respiratory syncytial virus (Liu et al., 2014), coronavirus (SARS-CoV and MERS-CoV) (Filardo et al., 2020), and rhinovirus (Mastromarino et al., 2015).
2.6 Flavonoids
Flavonoids are polyphenolic secondary metabolites found in plants. Extensive scientific literature is available on the antimicrobial and antiviral properties of catechins and epicatechins (Taylor et al., 2005; Reygaert, 2014). For example, epicatechin-3-gallate, epigallocatechin, and epigallocatechin-3-gallate have been shown to have antimicrobial effects against a variety of bacteria, including S. aureus, methicillin-resistant S. aureus (MRSA) and E. coli (Reygaert, 2014). Taylor et al. (2005) demonstrated that low concentrations of epicatechin gallate can sensitize MRSA clinical isolates to levels of oxacillin which can be readily achieved in clinical practice.
We have previously demonstrated the antibacterial effect of catechin and epicatechin against S. aureus ATCC 6538P (MIC values of 0.078–0.15 and 0.15 mg/mL, respectively) and H. pylori (both ATCC strains and clinical isolates, Bisignano et al. (2013b)) and the antiviral activity (decrease in the viral titer ** p < 0.01, and viral DNA accumulation * p < 0.05) of a polyphenols mix containing catechin, naringenin-7-O-glucoside, kaempferol-3-O-glucoside, epicatechin, isorhamnetin-3-O-rutinoside, and isorhamnetin-3-O-glucoside against HSV-1 (Musarra-Pizzo et al., 2019). Through Western blot, real-time polymerase chain reaction (PCR) and viral binding assay, we also demonstrated that polyphenols were able to block the production of infectious HSV-1 particles and inhibited HSV-1 adsorption to Vero cells (Bisignano et al., 2017).
The antimicrobial and antiviral activity of quercetin, and the possible mechanism of action, have recently been reviewed (Di Petrillo et al., 2022; Nguyen and Bhattacharya, 2022). Strong growth inhibition of different Gram-positive and Gram-negative bacteria has been reported, particularly affecting gastrointestinal, respiratory, urinary, and dermal system (Anand David et al., 2016) as well as the yeast C. albicans (Singh et al., 2015; Gao et al., 2016) the fungi Aspergillus fumigatus (Yin et al., 2021) and Aspergillus niger (Abd-Allah et al., 2015) and several viruses, such as the human immunodeficiency virus (HIV)-1 strain (Kim et al., 1998), the herpes simplex and the respiratory syncytial virus (Cushnie and Lamb, 2005), the polio-virus type 1 (Kaul et al., 1985) and the influenza virus (Liu et al., 2016). The mechanism of quercetin antimicrobial action includes cell membrane damage, change of membrane permeability, inhibition of synthesis of nucleic acids and proteins, reduction of expression of virulence factors, mitochondrial dysfunction, and prevention of biofilm formation.
We have previously reported the antibacterial potential of eriodictyol and naringenin: eriodictyol was more effective (MICs in the range of 250 and 800 μg/mL) compared with other tested flavonoids, such as naringenin, against a range of Gram-positive and Gram-negative bacteria (E. coli, Salm. enterica, P. putida, B. subtilis, L. innocua, Lactococcus lactis, S. aureus) and the yeast Saccharomyces cerevisiae (Mandalari et al., 2007). On the other hand, naringenin was active against S. aureus ATCC 6538P, L. monocytogenes ATCC 7466 and Salm. enterica ser. Typhimurium ATCC 14028 (MIC values of 250, 500 and 250 μg/mL), respectively (Mandalari et al., 2010). Periferakis et al. (2022) reviewed the antibacterial and antifungal properties of kaempferol. Pure kaempferol, kaempferol extracts and nanoparticles loaded with kaempferol have shown activity against Gram-negative bacteria, including Acinetobacter baumannii (Özçelik et al., 2006; Rofeal et al., 2021), Enterobacter cloacae (Christopoulou et al., 2008), Enterobacter aerogenes (Karimi et al., 2011), E. coli (Özçelik et al., 2006; Kannanoor et al., 2021), K. pneumoniae (Habbu et al., 2009), P. aeruginosa (Attallah et al., 2022), Vibrio cholerae (Martini et al., 2004), as well as Gram-positive bacteria, including S. aureus (Özçelik et al., 2006), Streptococcus pyogenes (Özçelik et al., 2006), Bacillus sp. (Youssef et al., 2021), and Mycobacterium sp. (Nguyen et al., 2021). Moreover, both isolated kaempferol-3-O-[3-O-acetyl-6-O-(E)-p-coumaroyl]-b-d-glucopyranoside and kaempferol 3-O-b-D-kaempferol 3-O-b-D-glucopyranoside, were found to be active in vitro against C. albicans, Candida glabrata and Candida tropicalis (Christopoulou et al., 2008).
Eriodictyol, naringenin and kaempferol have been identified as promising antiviral compounds against SARS-CoV-2, both alone and together existing antiviral drugs, targeting specifically the promising 3C-like protease (3CLpro) (Kaul et al., 2021).
A wide range of in vitro antibacterial activity has been reported for apigenin by Wang et al. (2019): apigenin was active against Acinetobacter baumannii (with MIC values between 2 and 64 μg/mL), Bacillus subtilis (MIC values between 8 and 16 μg/mL), Enterococcus faecalis ATCC 29212 (MIC = 8 μg/mL), E. coli ATCC 35818 (MIC = 4 μg/mL), K. pneumoniae RSKK 574 (MIC = 8 μg/mL) and ESβL+ clinical isolate (MIC = 128 μg/mL), Proteus mirabilis ATCC 7002, (MIC = 4 μg/mL), S. aureus ATCC 25923 (MIC = 16 μg/mL), and C. albicans ATCC 10231 (MIC = 8 μg/mL) (Özçelik et al., 2011). The therapeutic potential of apigenin against viral infection has recently been reviewed by Lee et al. (2023). Apigenin exerts virucidal activity against HSV-1 interfering with viral absorption and inhibiting the post-entry step of the viral replication (Lyu et al., 2005; Yucharoen, 2011; Visintini Jaime et al., 2013; Fahmy et al., 2020; Rittà et al., 2020), against Enterovirus 71 by inhibiting the interaction between internal ribosome entry site of EV71 and hnRNP A1 and A2 (Shih et al., 2011; Lv et al., 2014; Zhang et al., 2014; Ji et al., 2015; Dai et al., 2019), against hepatitis C virus by binding to NS5B and inhibiting RdRp activity, decreasing miR122 expression levels and suppressing the phosphorylation of TRBP (Manvar et al., 2012; Ohno et al., 2013; Pisonero-Vaquero et al., 2014; Shibata et al., 2014), against Dengue virus by restoring STAT2 Tyr 689 phosphorylation and activation, colocalization with a DENV protein in the early phase of infection (Mazzon et al., 2009; Jasso-Miranda et al., 2019; Acchioni et al., 2023), against SARS-CoV by reducing the production of proinflammatory cytokine in response to viral infection, as well as interacting with viral protein (Mpro) and host factor (ACE-2 receptor, TMPRSS2) (Ryu et al., 2010; Jo et al., 2020; Zhang et al., 2020; Alzaabi et al., 2022; Chaves et al., 2022; Farhat et al., 2022) as well as against influenza virus - by neuroaminidase inhibition, viral attachment and entry inhibition, inhibition of viral mRNA expression, inhibition of influenza A virus RdRP activity, reduction of viral particle production, and nucleoprotein reduction (Liu et al., 2008; Kai et al., 2014; Xu et al., 2020a, 2020b; Joo et al., 2022; Morimoto et al., 2023).
Amongst the flavanones, luteolin has also shown antibacterial potential against S. aureus and L. monocytogenes in vitro, by impairment effect on the cell membrane and restraining biofilm formation of both strains (Qian et al., 2020). A literature review on the antiviral mechanism of luteolin has recently been published by Lu et al. (2023): luteolin effectively inhibited coronavirus replication (Alzaabi et al., 2022; Chen et al., 2022), influenza virus (Lee et al., 2016), enterovirus (Chen et al., 2008; Cao et al., 2016), rotavirus (Knipping et al., 2012), herpes virus (Lu et al., 2023), and respiratory syncytial virus (Wang et al., 2020). In particular, it prevented viral infection by improving the host’s nonspecific immunity and antioxidation capacity, thus inhibiting several pathways related to viral infection, including MAPK, PI3K-AKT, TLR4/8, NF-κB, and Nrf-2/hemeoxygenase-1. Furthermore, luteolin was able to regulate the expression of specific receptors and factors, interfering with viral replication and thus promoting the repair of damaged cells induced by proinflammatory factors (Lu et al., 2023).
Hong et al. (2006) demonstrated in vitro the antibacterial potential of the isoflavone genistein against the Gram-positive S. aureus and Bacillus anthracis strains (Hong et al., 2006). Furthermore, an investigation on the mechanism of action of genistein indicated altered cell morphology (formation of filamentous cells) on bacterial cells, together with an inhibition of DNA and RNA synthesis as shortly as 15 min after addition to a bacterial culture. Protein synthesis inhibition was also detected (Ulanowska et al., 2006). Genistein has also been shown to possess antiviral activity against the herpes B virus, acting synergistically with existing antiviral drugs (LeCher et al., 2019). An effect of genistein as a general kinase inhibitor against an arenaviral haemorrhagic fever surrogate virus has also been demonstrated (Vela et al., 2010).
The antibacterial and antifungal effect of the isoflavone daidzein has been reported against S. aureus (both ATCC and clinical strains) by Lalouckova et al. (2021). Dietary daidzein was able to inhibit hepatitis C virus replication by decreasing microRNA-122 levels (He et al., 2021).
2.7 Anthocyanins
Anthocyanins are a group of red and blue pigments found in plants and along with catechins, form subgroups within the flavonoids. The antimicrobial activity of anthocyanins and catechins against the foodborne pathogens E. coli and Salmonella sp. has been reported, with MIC values between 10–400 mg/mL (Ma et al., 2019). Mechanistically, anthocyanins can act as an antibacterial by destroying the cell wall of foodborne pathogens: anthocyanins extracted from the Assegai tree (Curtisia dentata) were able to destroy the E. coli cell wall (Doughari et al., 2012), whereas in another study, anthocyanins extracted from lowbush wild blueberries were able to destroy the cell membranes of E. coli O157: H7, with consequent cytoplasmic leakage (Lacombe et al., 2013). Although anthocyanins are active against different bacterial strains, Gram-positive bacteria are usually more susceptible than Gram-negative bacteria (Cisowska et al., 2011). We have demonstrated the effect of an anthocyanin extract from the flowering plant Roselle (Hibiscus sabdariffa L.) containing cyanidin-3-O-sambubioside and delphinidin-3-O-sambubioside against S. aureus ATCC 6538 and against a food isolate of L. monocytogenes. The effect was bacteriostatic against S. aureus (MIC = 2.5 mg/mL) and bactericidal against L. monocytogenes (Minimal Bactericidal Concentration, MBC = 2.5 mg/mL) (El Majdoub et al., 2021).
The antiviral potential of anthocyanidins has been recently reviewed by Mohammadi Pour et al. (2019): a total anthocyanins extract from strawberry (Fragaria x ananassa) was active against HSV-1 (Simões et al., 2012), whereas an anthocyanins extract from wild strawberry (Fragaria vesca), raspberry (Rubus idaeus), blueberry (Vaccinium myrtillis) and lingonberry (Vaccinium vitis-idaea) was active against coxsackievirus B1 (CV-B1) and influenza A virus (Nikolaeva-Glomb et al., 2014). Specifically, cyanidin-3-galactoside, contained in pistachios, was active against the influenza A, influenza B and Avian influenza viruses by Increasing the NK cell activity and enhancing the immune system responses (Niemenak et al., 2006).
These reports illustrate the extensive antimicrobial and antiviral effects of pistachio phytochemicals, isolated or within plant extracts, alone and combined with existing drugs. In terms of antibacterial activity, Gram-positive strains were usually more susceptible than Gram-negative bacteria, with a mostly bacteriostatic rather than bactericidal effect. Amongst the Gram-positive bacterial strains tested, ATCC and clinical isolates of S. aureus were more susceptible to the effect of bioactive compounds. S. aureus and MRSA are known to be responsible of various infections, including biofilm-associated diseases, ranging from skin, prostheses, catheters and other biomaterials infections to more serious systemic diseases, such as endocarditis, pneumonia, and osteomyelitis. Given the increased incidence of antibiotic resistant S. aureus infections, especially within hospital settings, the discovery of natural compounds effective against S. aureus produced biofilm is a promising area for further clinical research (Mandalari et al., 2023).
3 Antimicrobial effect of pistachios and mechanism of action
Table 3 reports the antimicrobial effect of pistachio extracts and essential oil. We have previously demonstrated that polyphenol-rich extracts of natural raw shelled and roasted salted pistachios were active in vitro against a range of Gram-positive bacteria, with a bactericidal effect against ATCC strains and food isolates of L. monocytogenes, S. aureus and MRSA (Bisignano et al., 2013a). Furthermore, we have phenotypically characterized clinical isolates of Staphylococcus spp. and tested these for their sensitivity against natural raw and roasted salted pistachios: both extracts were active against clinical isolates of Staphylococcus sp., as well as the S. aureus ATCC 6538P (La Camera et al., 2018). We have also demonstrated that polyphenol-rich extracts of natural raw shelled and roasted salted pistachios were effective against L. monocytogenes food isolate strains (MIC values between 0.25 and 2.0 mg/mL) and against L. monocytogenes ATCC 13932 (Gervasi et al., 2022). Furthermore, the oil fractions from natural and roasted pistachios were effective against L. monocytogenes ATCC 13932 and Enterococcus faecium DSZM 17050. Other authors have confirmed the effect of a methanolic extract of pistachios against staphylococcal infections (Gutiérrez-Morales et al., 2017). Pistacia vera L. oleoresin has been tested in combination with levofloxacin, demonstrating a protective effect against H. pylori infection in an in vivo model of Galleria mellonella (62 and 63% survival using oleoresin and levofloxacin, respectively) (Di Lodovico et al., 2019). Pistacia vera L. oleoresin was also effective against oral streptococci, such S. mutans, with a demonstrated anti-biofilm activity (Magi et al., 2018).
Table 3
| Pistachio | Strain | Active concentration | Reference |
|---|---|---|---|
| Natural raw and roasted salted polyphenols-rich extracts of Pistacia vera L. | L. monocytogenes, S. aureus and MRSA | 15.6–125.0 μg/mL | Bisignano et al. (2013a) |
| Natural raw and roasted salted polyphenols-rich extracts of Pistacia vera L. | Staph. spp. | 31.2–2000.0 μg/mL | La Camera et al. (2018) |
| Natural raw and roasted salted polyphenols-rich extracts of Pistacia vera L. | L. monocytogenes ATCC and food isolates | 0.25–2.0 mg/mL | Gervasi et al. (2022) |
| Methanolic extract of Pistacia vera L. | Staph. spp. | 68.6 ± 0.3% relative percentage inhibition | Gutiérrez-Morales et al. (2017) |
| Pistacia vera L. oleoresin | H. pylori infection in an in vivo model of Galleria mellonella | 62% survival rate | Di Lodovico et al. (2019) |
| Pistacia vera L. oleoresin | Streptococcus spp. | 1024.0–2048.0 μg/mL | Magi et al. (2018) |
| Essential oil from Pistacia vera L. hulls | S. aureus and E. coli | 7.1 mg/ mL | Smeriglio et al. (2017) |
| Essential oil from Pistacia vera L. hulls | Candida spp. | 2.5–5.0 mg/ mL | D’Arrigo et al. (2019) |
| Essential oil from Pistacia vera L. hulls | S. aureus, B. subtilis, A. flavus | 60.0–500.0 μg/mL | Shahdadi et al. (2023) |
| Pistachio hull ethanolic (PVE) and aqueous (PVD) extracts | E. faecalis, S. aureus, S. uberis, B. cereus and B. subtilis | 0.8–49.0 (PVE) and 9.6–82.5 (PVD) mg/mL | Seker and Akbas (2023) |
| Pistachio hull extract | E. coli, B. cereus, S. aureus, P. aeruginosa, A. niger, C. albicans | 0–22 mm growth diameter | Bakhshi et al. (2021) |
Antimicrobial effect of pistachio extracts and essential oil.
The essential oil from Pistacia vera L. hulls was bactericidal against a range of S. aureus strains and E. coli at a concentration of 7.11 mg/mL (Smeriglio et al., 2017). A fungicidal effect of pistachio essential oil was demonstrated against standard and clinical strains of Candida sp. at concentrations between 2.50 and 5.0 mg/mL, D-limonene and 3-Carene being the most active components (D’Arrigo et al., 2019). The inhibitory activity of pistachio hull essential oil has also recently been demonstrated against S. aureus, B. subtilis and Aspergillus flavus (Shahdadi et al., 2023).
Recently, the phytochemical contents, the antioxidant and antimicrobial activities of pistachio hull ethanolic (PVE) and aqueous (PVD) extracts obtained by microwave-assisted extraction (MAE) were investigated by Seker and Akbas (2023): both extracts showed antimicrobial potential against E. faecalis, S. aureus, Streptococcus uberis, B. cereus and B. subtilis, with MICs values between 0.8–49.0 and 9.6–82.5 mg/mL and MBC values ranging from 1.3–99.1 and 15.5–150.0 mg/mL for PVE and PVD, respectively (Seker and Akbas, 2023). The antibacterial properties of pistachio hull extracts have also been reviewed by Arjeh et al. (2020).
A pistachio hull extract has been used as a reducing and stabilizing agent with antibacterial and antifungal effects within copper nanoparticles (Bakhshi et al., 2021).
Overall, these studies demonstrate that pistachios extract and essential oil, alone or in association with existing drugs, could be considered good candidates for the development of novel drug formulations. Their activity against Gram-positive bacterial strains, including S. aureus, could be exploited to identify novel therapeutics with topical use (i.e., to treat skin infections).
Although further studies are warranted to evaluate the mechanisms of action involved in the observed effect exerted by pistachio extracts, Figure 1 reports some proposed molecular bacterial targets, as reviewed by Álvarez-Martínez et al. (Álvarez-Martínez et al., 2020). Polyphenols can target the bacterial cell wall, causing morphological damage to the cells, or destroying the structural integrity of the cell wall and intracellular matrix (Din et al., 2013; Pojer et al., 2013).
Figure 1
The different cell wall structure between Gram-positive and Gram-negative bacteria could explain the higher susceptibility of Gram-positive strains to phytochemical antimicrobial activity, given that the outer membrane of Gram-negative bacteria acts as a permeability barrier, therefore reducing the uptake of the phenolic compounds (Naz et al., 2007). Polyphenols can cause leakage by increased permeability of the bacterial membrane and the cell wall (Lambert et al., 2001; Wang et al., 2017). Specifically, catechins can cause destruction of the Gram-positive bacterial membranes through interaction with lipids, which determine phase separations (Reygaert, 2014). Furthermore, epicatechin, tannic acid, epigallocatechin gallate, quercetin and kaempferol demonstrated significant β -lactamase inhibitory activity, also in synergy with antibiotics such as ciprofloxacin and rifampicin (Lin et al., 2008; Bernal et al., 2010; Mandal et al., 2017). Other possible targets could be represented by cell surface adhesion proteins, membrane-bound enzymes and cell wall polypeptides (Naz et al., 2007). A bioactive fraction from the tree species Duabanga grandiflora fruit has been shown to inhibit the penicillin-binding protein 2a in MRSA strains (Santiago et al., 2015).
Regulation of bacterial gene expression has been proposed as an alternative mechanism of action by phytochemicals, either through modulation of transcription factors or direct interaction with DNA. The antibacterial effect of Caffeic Acid Phenethyl Ester (CAPE) against E. faecalis, L. monocytogenes and S. aureus has been also related to its ability to target RNA- and DNA-related molecules (Murtaza et al., 2014). Naringenin was able to bind the DNA of S. aureus ATCC 6538, resulting in major metabolic changes (Wang et al., 2017). Furthermore, the effect of phytochemicals on biofilm formation has been reported: for example, we have shown a dose-dependent effect of phloretin on biofilm production of S. aureus (Mandalari et al., 2023) and a dose-dependent effect of a white grape juice extract on biofilms formation of E. coli and Pseudomonas aeruginosa (Filocamo et al., 2015). Another antibacterial effect of phytochemicals is related to the alteration of the level of bacterial metabolites, proton and ion equilibrium and adenosine triphosphate (ATP) synthesis inhibition, which could determine cell death (Lin et al., 2005; Engels et al., 2011). Certain polyphenols, such as gallic or caffeic acid, could reduce cytochrome activity and, therefore, oxidative phosphorylation, thus inhibiting bacterial growth (Shetty and Wahlqvist, 2004; Kwon et al., 2007).
It is worth noting that the antibacterial effect of polyphenolic plant extracts is often the result of synergistic, indifferent, or antagonistic interactions among the individual compounds. For example, we have demonstrated that bergamot (Citrus bergamia) fractions and the pure phytochemical compounds, neohesperidin, hesperetin (aglycone), neoeriocitrin, eriodictyol (aglycone), naringin and naringenin (aglycone), were active against Gram-negative bacteria (E. coli, Pseudomonas putida, Salm. enterica) with MIC values in the range 200 to 800 μg/mL. However, pairwise combinations of eriodictyol, naringenin and hesperetin showed synergistic and indifferent interactions, dependent on the selected, tested organism (Mandalari et al., 2007). Moreover, isolated phytochemicals and extracts are being used in combination with traditional antibiotics to sensitize multidrug-resistant bacterial strains (Hatano et al., 2005; Betoni et al., 2006). We have demonstrated a synergistic and post-antibiotic effect of tobramycin in combination with tea tree (Melaleuca alternifolia) oil against S. aureus and E. coli (D’Arrigo et al., 2010). This strategy could represent a valuable tool to combat AMR more effectively.
4 Antiviral effect of pistachios and mechanism of action
Figure 2 illustrates the effectiveness of bioactive natural compounds against viral families. The antiviral potential of pistachio polyphenolic extracts, particularly against herpes simplex virus type 1 (HSV-1), has been demonstrated (Table 4). We have previously shown that natural raw pistachio extracts (NRRE) significantly reduced the expression of critical viral proteins, including ICP8 (infected cell polypeptide 8), UL42 (DNA polymerase processivity factor), and US11. This reduction was associated with a decrease in viral DNA synthesis, highlighting the extract’s inhibitory effects on HSV-1 replication (Musarra-Pizzo et al., 2020). More recently, we have further investigated the mechanisms involved in the anti-HSV-1 effect exerted by pistachio extracts (Figure 3): NRRE and roasted unsalted (RURE) pistachio polyphenols-rich extracts blocked virus binding on the cell surface, impaired viral DNA synthesis, and prevented the accumulation of viral proteins (Pennisi et al., 2023). Indeed, by testing six compounds present in pistachio polyphenolic extracts (α, β, and δ tocopherol, β-carotene, luteolin, and zeaxanthin), we have demonstrated that zeaxanthin inhibited HSV-1 replication by affecting both viral internalization and replication. Furthermore, zeaxanthin directly interacted with HSV-1 viral particles, leading to a significant reduction in HSV-1 replication (CC50 16.1, EC50 4.08 μM, SI 3.96). Additionally, Özçelik et al. (2005) explored the antiviral properties of 15 lyophilic extracts from various parts of Pistacia vera, including leaves, branches, stems, kernels, shell skins, and seeds. Their research identified kernel and seed extracts as having the most potent antiviral effects against herpes simplex and parainfluenza viruses. Specifically, the fresh kernel (PV-FK) and skin of processed-woody shell (PV-SPS) extracts demonstrated significant activity against DNA viruses, which well compared with acyclovir (Figure 3). The Gaziantep sample-unripe (PV-GU) extract also showed notable antiviral activity. On the other hand, some extracts displayed outstanding activity against RNA viruses, such as PV-GR (Gaziantep sample-ripe) and PV-GP (Gaziantep sample-processed). Chhoud et al. (2022) reported the anti-HSV-2 activity of extracts from Pistacia vera male floral buds: the aqueous and polysaccharide extracts from male flower buds exhibited a selectivity index (SI) of 29.12 and 20.25, respectively. The extracts showed virucidal activity against HSV-2, likely by altering the viral membrane or interacting with viral ligands, thus inhibiting their binding to receptors on target cells. Finally, pistachio extracts have shown activity against Coxsackie viruses (CV) B2, B3, B4, and B5. Specifically, two pistachio allergens, 2S albumin (Pis v 1) and 11S globulin (Pis v 2.0101), were found to inhibit these viruses (Taghizadeh et al., 2020).
Figure 2
Table 4
| Compound | Class | Virus | Antiviral effect | SI | Reference |
|---|---|---|---|---|---|
| NRRE n-hexane | Polyphenolic extracts | HSV-1 | Viral inactivation Binding inhibition Viral DNA reduction Viral proteins reduction | 9.2 | Pennisi et al. (2023) |
| RURE n-hexane | Polyphenolic extracts | Viral inactivation Binding inhibition Viral DNA reduction Viral proteins reduction | 4.98 | ||
| Zeaxanthin | Carotenoids | Viral inactivation Binding inhibition Viral DNA reduction | 3.96 | ||
| NPRE | Polyphenol-rich extracts | HSV-1 | Viral DNA reduction Viral proteins reduction | 3 | Musarra-Pizzo et al. (2020) |
| NP mix | Catechin, eriodictyol-7- O-glucoside, gallic acid, protocatechuic acid, caffeic acid, rutin, and isoquercetin | Binding inhibition Viral DNA reduction | - | ||
| PV-FK | Lipophylic extracts | HSV-1 | Viral replication | - | Özçelik et al. (2005) |
| PV-SPS | Lipophylic extracts | HSV-1 | - | ||
| PV-GU | Lipophylic extracts | HSV-1 | - | ||
| PV-GR | Lipophylic extracts | HSV-1, Parainfluenza viruses | - | ||
| PV-GP | Lipophylic extracts | HSV-1 Parainfluenza viruses | - | ||
| AE-Pis | Aqueous extracts | HSV-2 | Viral replication Viral inactivation | 29.12 | Chhoud et al. (2022) |
| P-Pis | Polysaccharide extracts | 20.25 | |||
| Pis v 1 | Allergenic protein Estracts | CV- B2, CV- B3, CV-B4, and CV-B5 | Inhibitory activity of virus-induced cytopathogenicity | 7.33 (CV- B2) 11.80 (CV-B3) 16.35 (CV-B4) 14.21 (CV-B5) | Taghizadeh et al. (2020) |
| Pis v 2.0101 | 17.30 (CV- B2) 18.25 (CV-B3) 23.52 (CV-B4) 20.41 (CV-B5) |
Antiviral effect of pistachios extracts.
NRRE n-hexane: n-hexane-extracted Californian natural raw pistachio polyphenols-rich extracts; RURE n-hexane: n-hexane-extracted Californian roasted raw pistachio polyphenols-rich extracts; NPRE: natural shelled pistachios kernels; NP mix: natural shelled pistachio kernels mix; PV-FK: Pistacia vera fresh kernel; PV-SPS: Pistacia vera skin of processed-woody shell; PV-GU: Pistacia vera Gaziantep sample-unripe; PV-GR: Pistacia vera Gaziantep sample-ripe; PV-GP: Pistacia vera Gaziantep sample-processed; AE-Pis: Aqueous extract from Pistacia vera L. male floral buds; P-Pis: Polysaccharide from Pistacia vera L. male floral buds; HSV-1: Herpes Simplex Virus type 1; HSV-2: Herpes Simplex Virus type 2; CV: Coxsackie viruses; SI: selectivity index: the ratio of EC50/CC50.
Figure 3
5 Conclusion
Due to the increased rates of resistance to antibiotics and antivirals, scientific research is continuously developing to find novel cost-effective alternatives to reduce hospitalization and mortality rates. Amongst natural compounds, the phytochemicals present in pistachio nuts have been shown to exhibit significant antibacterial and antiviral activity against resistant and non-resistant strains. Some findings suggest that the antimicrobial and antiviral effects of pistachio polyphenolic extracts are the result of a balance of the individual bioactive compounds which in combination exert the activity. The synergistic interaction of certain phytochemicals with selected antibiotics or antiviral drugs could be a useful tool to overcome resistance. Nevertheless, isolated compounds, such as zeaxanthin, exhibit strong antiviral activity against HSV-1, affecting viral attachment, penetration and viral DNA synthesis.
While the mechanism of action of pistachio extracts has been partly elucidated, further studies are required to identify more bioactive compounds responsible for the observed effect. However, based on the existing evidence, the use of pistachio extracts and derivatives should be encouraged for the topical treatment of S. aureus skin infections and ocular herpetic infections. Existing challenges in the development of antimicrobials from natural products, including cytotoxicity, production of highly active standardized extracts with defined mechanism of action under GMP conditions, and identification of bioactive components taking into account possible interaction amongst the individual compounds, should also be considered, together potential sustainability issues related to pistachio cultivation.
Statements
Author contributions
GM: Conceptualization, Data curation, Funding acquisition, Project administration, Writing – original draft, Writing – review & editing. RP: Writing – review & editing. TG: Writing – review & editing. MS: Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The work has been funded by the American Pistachio Growers (APG, United States).
Acknowledgments
The authors would like to express their gratitude to Paola Trischitta for her valuable graphical contribution.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
AMR, Antimicrobial resistance; ATCC, American Type Culture Collection; ATP, Adenosine triphosphate; B. subtilis, Bacillus subtilis; C. albicans, C. albicans; EGC, Epigallocatechin; E. coli, Escherichia coli; FRAP, Ferric-reducing antioxidant power; H. pylori, Helicobacter pylori; HSV-1, Herpes simplex virus 1; HSV-2, Herpes simplex virus 2; K. pneumoniae, Klebsiella pneumoniae; L. innocua, Listeria innocua; L. monocytogenes, Listeria monocytogenes; MIC, Minimum inhibitory concentration; MBC, Minimum bactericidal concentration; MRSA, Methicillin-Resistant Staphylococcus aureus; NK, Natural killer; P. aeruginosa, Pseudomonas aeruginosa; P. putida, Pseudomonas putida; Salm. enterica, Salmonella enterica; S. aureus, Staphylococcus aureus; S. saprophyticus, Staphylococcus saprophyticus; TPC, Total phenolic content.
Footnotes
1.^U.S. Department of Agriculture, Agricultural Research Service. FoodData Central. Available online: fdc.nal.usda.gov (Accessed December 16, 2023).
2.^Nutrient Data Laboratory; Beltsville Human Nutrition Research Center Agricultural Research Service. USDA Database for the Flavonoid Content of Selected Foods Release 3.3. Available at: https://www.ars.usda.gov/ARSUserFiles/80400535/Data/Flav/Flav3.3.pdf (Accessed December 16, 2023).
3.^Nutrient Data Laboratory; Beltsville Human Nutrition Research Center; Agricultural Research Service; USDA Database for the Proanthocyanidin Content of Selected Foods Release 2.12018 Available at: https://www.ars.usda.gov/ARSUserFiles/80400535/Data/PA/PA02-1.pdf (Accessed December 16, 2023).
4.^US Department of Agriculture USDA, http://www.ars.usda.gov/nutrientdata.
5.^Phenol-Explorer database http://phenol-explorer.eu/contents.
References
1
Abd-AllahW. E.AwadH. M.AbdelMohsenM. M. (2015). HPLC analysis of quercetin and antimicrobial activity of comparative methanol extracts of Shinus molle L. Int. J. Curr. Microbiol. App. Sci.4, 550–558.
2
AbdulhadiS. Y.GergeesR. N.HasanG. Q. (2020). Molecular identification, antioxidant efficacy of phenolic compounds, and antimicrobial activity of Beta-carotene isolated from fruiting bodies of Suillus sp. Karbala Int. J. Mod. Sci.6. doi: 10.33640/2405-609X.1966
3
AbediniE.KhodadadiE.ZeinalzadehE.MoaddabS. R.AsgharzadehM.MehramouzB.et al. (2021). A comprehensive study on the antimicrobial properties of resveratrol as an alternative therapy. Evid. Based Complement. Alternat. Med.2021, 1–15. doi: 10.1155/2021/8866311
4
AcchioniC.AcchioniM.ManciniF.AmendolaA.MarsiliG.TirelliV.et al. (2023). A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation. Virology583, 1–13. doi: 10.1016/j.virol.2023.03.016
5
AlqurashiA. S.Al MasoudiL. M.HamdiH.Abu ZaidA. (2022). Chemical composition and antioxidant, antiviral, antifungal, antibacterial and anticancer potentials of Opuntia ficus-indica seed oil. Molecules27:5453. doi: 10.3390/molecules27175453
6
Álvarez-MartínezF. J.Barrajón-CatalánE.EncinarJ. A.Rodríguez-DíazJ. C.MicolV. (2020). Antimicrobial capacity of plant polyphenols against gram-positive Bacteria: A comprehensive review. Curr. Med. Chem.27, 2576–2606. doi: 10.2174/0929867325666181008115650
7
AlzaabiM. M.HamdyR.AshmawyN. S.HamodaA. M.AlkhayatF.KhademiN. N.et al. (2022). Flavonoids are promising safe therapy against COVID-19. Phytochem. Rev.21, 291–312. doi: 10.1007/s11101-021-09759-z
8
Anand DavidA.ArulmoliR.ParasuramanS. (2016). Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn. Rev.10, 84–89. doi: 10.4103/0973-7847.194044
9
Antibiotic resistance threats in the United States. (2019). Atlanta, Georgia.
10
ArjehE.AkhavanH.-R.BarzegarM.Carbonell-BarrachinaÁ. A. (2020). Bio-active compounds and functional properties of pistachio hull: A review. Trends Food Sci. Technol.97, 55–64. doi: 10.1016/j.tifs.2019.12.031
11
AttallahN. G. M.El-SherbeniS. A.El-KademA. H.ElekhnawyE.El-MasryT. A.ElmongyE. I.et al. (2022). Elucidation of the metabolite profile of Yucca gigantea and assessment of its cytotoxic, antimicrobial, and anti-inflammatory activities. Molecules27:1329. doi: 10.3390/molecules27041329
12
AugustineN.GoelA. K.SivakumarK. C.Ajay KumarR.ThomasS. (2014). Resveratrol – A potential inhibitor of biofilm formation in Vibrio cholerae. Phytomedicine21, 286–289. doi: 10.1016/j.phymed.2013.09.010
13
BakhshiO.BagherzadeG.Ghamari kargarP. (2021). Biosynthesis of organic nanocomposite using Pistacia vera L. Hull: An efficient antimicrobial agent. Bioinorg. Chem. Appl.2021, 1–18. doi: 10.1155/2021/4105853
14
BanerjeeS.SarkarR.MukherjeeA.MiyoshiS. I.KitaharaK.HalderP.et al. (2022). Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway. Front. Microbiol.13:951716. doi: 10.3389/fmicb.2022.951716
15
BellomoM. G.FallicoB. (2007). Anthocyanins, chlorophylls and xanthophylls in pistachio nuts (Pistacia vera) of different geographic origin. J. Food Compos. Anal.20, 352–359. doi: 10.1016/j.jfca.2006.04.002
16
BernalP.LemaireS.PinhoM. G.MobasheryS.HindsJ.TaylorP. W. (2010). Insertion of Epicatechin Gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated β-lactam resistance by delocalizing PBP2. J. Biol. Chem.285, 24055–24065. doi: 10.1074/jbc.M110.114793
17
BertoloniG.RossiF.ValdugaG.JoriG.AliH.van LierJ. E. (1992). Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios71, 33–46
18
BetoniJ. E. C.MantovaniR. P.BarbosaL. N.Di StasiL. C.Fernandes JuniorA. (2006). Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem. Inst. Oswaldo Cruz101, 387–390. doi: 10.1590/S0074-02762006000400007
19
BisignanoC.FilocamoA.FaulksR. M.MandalariG. (2013a). In vitro antimicrobial activity of pistachio (Pistacia vera L.) polyphenols. FEMS Microbiol. Lett.341, 62–67. doi: 10.1111/1574-6968.12091
20
BisignanoC.FilocamoA.La CameraE.ZummoS.FeraM. T.MandalariG. (2013b). Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Microbiol.13:103. doi: 10.1186/1471-2180-13-103
21
BisignanoC.MandalariG.SmeriglioA.TrombettaD.PizzoM.PennisiR.et al. (2017). Almond skin extracts abrogate HSV-1 replication by blocking virus binding to the cell. Viruses9:178. doi: 10.3390/v9070178
22
BollingB. W.BlumbergJ. B.Oliver ChenC.-Y. (2010a). The influence of roasting, pasteurisation, and storage on the polyphenol content and antioxidant capacity of California almond skins. Food Chem.123, 1040–1047. doi: 10.1016/j.foodchem.2010.05.058
23
BollingB. W.ChenC.-Y. O.McKayD. L.BlumbergJ. B. (2011). Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr. Res. Rev.24, 244–275. doi: 10.1017/S095442241100014X
24
BollingB. W.McKayD. L.BlumbergJ. B. (2010b). The phytochemical composition and antioxidant actions of tree nuts. Asia Pac. J. Clin. Nutr.19, 117–123
25
BullóM.Juanola-FalgaronaM.Hernández-AlonsoP.Salas-SalvadóJ. (2015). Nutrition attributes and health effects of pistachio nuts. Br. J. Nutr.113, S79–S93. doi: 10.1017/S0007114514003250
26
CaoZ.DingY.KeZ.CaoL.LiN.DingG.et al. (2016). Luteoloside acts as 3C protease inhibitor of enterovirus 71 in vitro. PLoS One11:e0148693. doi: 10.1371/journal.pone.0148693
27
CDC. (2019). Antibiotic resistance threats in the United States. Atlanta, Georgia.
28
ChavesO. A.Fintelman-RodriguesN.WangX.SacramentoC. Q.TemerozoJ. R.FerreiraA. C.et al. (2022). Commercially available Flavonols are better SARS-CoV-2 inhibitors than Isoflavone and flavones. Viruses14:1458. doi: 10.3390/v14071458
29
ChenC.LiangH.DengY.YangX.LiX.HouC. (2022). Analysis and identification of bioactive compounds of cannabinoids in Silico for inhibition of SARS-CoV-2 and SARS-CoV. Biomol. Ther.12:1729. doi: 10.3390/biom12121729
30
ChenT.-C.WengK.-F.ChangS.-C.LinJ.-Y.HuangP.-N.ShihS.-R. (2008). Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother.62, 1169–1173. doi: 10.1093/jac/dkn424
31
ChhoudR.BouslamaL.GharbiD.NouiraF.PapettiA.MajdoubH. (2022). Identification of an anti-herpetic compound isolated from Pistacia vera L. male floral buds. 3 Biotech12:336. doi: 10.1007/s13205-022-03393-y
32
ChoudharyD.PanM.-H. (2020). Antiviral effects of Anthocyanins and phytochemicals as natural dietary compounds on different virus sources. Curr. Res. Nutr. Food Science J.8, 674–681. doi: 10.12944/CRNFSJ.8.3.01
33
ChristopoulouC.GraikouK.ChinouI. (2008). Chemosystematic value of chemical constituents from Scabiosa hymettia (Dipsacaceae). Chem. Biodivers.5, 318–323. doi: 10.1002/cbdv.200890029
34
CisowskaA.WojniczD.HendrichA. B. (2011). Anthocyanins as antimicrobial agents of natural plant origin. Nat. Prod. Commun.6, 149–156. doi: 10.1177/1934578X1100600136
35
CushnieT. P. T.LambA. J. (2005). Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents26, 343–356. doi: 10.1016/j.ijantimicag.2005.09.002
36
D’ArrigoM.BisignanoC.IrreraP.SmeriglioA.ZagamiR.TrombettaD.et al. (2019). In vitro evaluation of the activity of an essential oil from Pistacia vera L. variety Bronte hull against Candida sp. BMC Complement. Altern. Med.19:6. doi: 10.1186/s12906-018-2425-0
37
D’ArrigoM.GinestraG.MandalariG.FurneriP. M.BisignanoG. (2010). Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli. Phytomedicine17, 317–322. doi: 10.1016/j.phymed.2009.07.008
38
DaiW.BiJ.LiF.WangS.HuangX.MengX.et al. (2019). Antiviral efficacy of flavonoids against enterovirus 71 infection in vitro and in newborn mice. Viruses11:625. doi: 10.3390/v11070625
39
Di LodovicoS.NapoliE.Di CampliE.Di FermoP.GentileD.RubertoG.et al. (2019). Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains. Sci. Rep.9:4646. doi: 10.1038/s41598-019-40991-y
40
Di PetrilloA.OrrùG.FaisA.FantiniM. C. (2022). Quercetin and its derivates as antiviral potentials: A comprehensive review. PTR36, 266–278. doi: 10.1002/ptr.7309
41
DinW. M.JinK. T.RamliR.KhaithirT. M. N.WiartC. (2013). Antibacterial effects of Ellagitannins from Acalypha wilkesiana var. macafeana hort.: surface morphology analysis with environmental scanning Electron microcopy and synergy with antibiotics. Phytother. Res.27, 1313–1320. doi: 10.1002/ptr.4876
42
DjouonzoP. T.MukimM. S. I.KemdaP. N.KowaT. K.TchindaA. T.Agbor AgborG.et al. (2023). SARS-CoV-2 Main protease inhibitors from the stem barks of Discoglypremna caloneura (Pax) Prain (Euphorbiaceae) and Pterocarpus erinaceus Poir (Fabaceae) and their molecular docking investigation. Appl. Biol. Chem.66:76. doi: 10.1186/s13765-023-00833-y
43
DoughariJ. H.NdakidemiP. A.HumanI. S.BenadeS. (2012). Antioxidant, antimicrobial and antiverotoxic potentials of extracts of Curtisia dentata. J. Ethnopharmacol.141, 1041–1050. doi: 10.1016/j.jep.2012.03.051
44
DuarteA.AlvesA. C.FerreiraS.SilvaF.DominguesF. C. (2015). Resveratrol inclusion complexes: antibacterial and anti-biofilm activity against Campylobacter spp. and Arcobacter butzleri. Food Res. Int.77, 244–250. doi: 10.1016/j.foodres.2015.05.047
45
El MajdoubY. O.GinestraG.MandalariG.DugoP.MondelloL.CacciolaF. (2021). The digestibility of Hibiscus sabdariffa L. polyphenols using an in vitro Human digestion model and evaluation of their antimicrobial activity. Nutrients13:2360. doi: 10.3390/nu13072360
46
EngelsC.SchieberA.GänzleM. G. (2011). Inhibitory spectra and modes of antimicrobial action of Gallotannins from mango kernels (Mangifera indica L.). Appl. Environ. Microbiol.77, 2215–2223. doi: 10.1128/AEM.02521-10
47
FahmyN. M.Al-SayedE.MoghannemS.AzamF.El-ShazlyM.SingabA. N. (2020). Breaking down the barriers to a natural antiviral agent: antiviral activity and molecular docking of Erythrina speciosa extract, fractions, and the major compound. Chem. Biodivers.17:e1900511. doi: 10.1002/cbdv.201900511
48
FanunzaE.IampietroM.DistintoS.CoronaA.QuartuM.MaccioniE.et al. (2020). Quercetin blocks Ebola virus infection by counteracting the VP24 interferon-inhibitory function. Antimicrob. Agents Chemother.64, e00530–e00520. doi: 10.1128/AAC.00530-20
49
FarhatA.Ben HlimaH.KhemakhemB.Ben HalimaY.MichaudP.AbdelkafiS.et al. (2022). Apigenin analogues as SARS-CoV-2 main protease inhibitors: in-silico screening approach. Bioengineered13, 3350–3361. doi: 10.1080/21655979.2022.2027181
50
FerreiraS.SilvaF.QueirozJ. A.OleastroM.DominguesF. C. (2014). Resveratrol against Arcobacter butzleri and Arcobacter cryaerophilus: activity and effect on cellular functions. Int. J. Food Microbiol.180, 62–68. doi: 10.1016/j.ijfoodmicro.2014.04.004
51
FilardoS.Di PietroM.MastromarinoP.SessaR. (2020). Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol. Ther.214:107613. doi: 10.1016/j.pharmthera.2020.107613
52
FilocamoA.BisignanoC.MandalariG.NavarraM. (2015). In vitro antimicrobial activity and effect on biofilm production of a white grape juice (Vitis vinifera) extract. Evid. Based Complement. Alternat. Med.2015, 1–5. doi: 10.1155/2015/856243
53
Freitas da SilvaF. E.das Chagas Lima PintoF.Loiola PessoaO. D.Marques da FonsecaA.Martins da CostaJ. G.Pinheiro SantiagoG. M. (2023). Campesterol semi-synthetic derivatives as potential antibacterial: in vitro and in silico evaluation. Chem. Biodivers.20:e202300536. doi: 10.1002/cbdv.202300536
54
GaoM.WangH.ZhuL. (2016). Quercetin assists fluconazole to inhibit biofilm formations of fluconazole-resistant Candida Albicans in in vitro and in vivo antifungal managements of vulvovaginal candidiasis. Cell. Physiol. Biochem.40, 727–742. doi: 10.1159/000453134
55
GentileC.TesoriereL.ButeraD.FazzariM.MonasteroM.AllegraM.et al. (2007). Antioxidant activity of Sicilian pistachio (Pistacia vera L. Var. Bronte) nut extract and its bioactive components. J. Agric. Food Chem.55, 643–648. doi: 10.1021/jf062533i
56
GervasiT.BarrecaD.LaganàG.MandalariG. (2021). Health benefits related to tree nut consumption and their bioactive compounds. Int. J. Mol. Sci.22:5960. doi: 10.3390/ijms22115960
57
GervasiT.D’ArrigoM.RandoR.SciortinoM. T.CarughiA.BarrecaD.et al. (2022). The antimicrobial potential of hexane oils and polyphenols-rich extracts from Pistacia vera L. Appl. Sci.12:4389. doi: 10.3390/app12094389
58
GhırardelloD.ProsperınıS.ZeppaG.GerbıV. (2010). Phenolic acid profile and antioxidant capacity of hazelnut (Corylus Avellana L.) kernels ˙In different solvent systems. J. Food Nutr. Res.49, 195–205.
59
GiuffridaD.SaittaM.La TorreG. L.BombaciL.DugoG. (2006). Carotenoid, chlorophyll and chlorophyll-derived compounds in pistachio kernels (Pistacia vera L.) from Sicily. Ital J Food Sci18, 309–316.
60
GrippiF.CrostaL.AielloG.TolomeoM.OliveriF.GebbiaN.et al. (2008). Determination of stilbenes in Sicilian pistachio by high-performance liquid chromatographic diode array (HPLC-DAD/FLD) and evaluation of eventually mycotoxin contamination. Food Chem.107, 483–488. doi: 10.1016/j.foodchem.2007.07.079
61
Gutiérrez-MoralesA.Velázquez-OrdoñezV.KhusroA.SalemA. Z. M.Estrada-ZúñigaM. E.SalemM. Z. M.et al. (2017). Anti-staphylococcal properties of Eichhornia crassipes, Pistacia vera, and Ziziphus amole leaf extracts: isolates from cattle and rabbits. Microb. Pathog.113, 181–189. doi: 10.1016/j.micpath.2017.10.015
62
HabbuP. V.MahadevanK. M.ShastryR. A.ManjunathaH. (2009). Antimicrobial activity of flavanoid sulphates and other fractions of Argyreia speciosa (Burm.F) Boj. Indian J. Exp. Biol.47, 121–128
63
HatanoT.KusudaM.InadaK.OgawaT.ShiotaS.TsuchiyaT.et al. (2005). Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry66, 2047–2055. doi: 10.1016/j.phytochem.2005.01.013
64
HayashiK.MoriM.KnoxY. M.SuzutanT.OgasawaraM.YoshidaI.et al. (2003). Anti influenza virus activity of a red-fleshed potato anthocyanin. Food Sci. Technol. Res.9, 242–244. doi: 10.3136/fstr.9.242
65
HayashiM.NaknukoolS.HayakawaS.OgawaM.Ni’matulahA.-B. A. (2012). Enhancement of antimicrobial activity of a lactoperoxidase system by carrot extract and β-carotene. Food Chem.130, 541–546. doi: 10.1016/j.foodchem.2011.07.067
66
HeY.HuangM.TangC.YueY.LiuX.ZhengZ.et al. (2021). Dietary daidzein inhibits hepatitis C virus replication by decreasing microRNA-122 levels. Virus Res.298:198404. doi: 10.1016/j.virusres.2021.198404
67
HongH.LandauerM. R.ForiskaM. A.LedneyG. D. (2006). Antibacterial activity of the soy isoflavone genistein. J. Basic Microbiol.46, 329–335. doi: 10.1002/jobm.200510073
68
JamhourR. M. A. Q.Al-NadafA. H.WedianF.Al-MazaidehG. M.MustafaM.HuneifM. A.et al. (2022). Phytochemicals as a potential inhibitor of COVID-19: An in-Silico perspective. Russ. J. Phys. Chem. A96, 1589–1597. doi: 10.1134/S0036024422070251
69
Jasso-MirandaC.Herrera-CamachoI.Flores-MendozaL. K.DominguezF.Vallejo-RuizV.Sanchez-BurgosG. G.et al. (2019). Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies. Infect Drug Resist12, 1833–1852. doi: 10.2147/IDR.S210890
70
JiP.ChenC.HuY.ZhanZ.PanW.LiR.et al. (2015). Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Biological ^|^. Pharm. Bull.38, 1–6. doi: 10.1248/bpb.b14-00357
71
Jimenez-AlemanG. H.CastroV.LondaitsbehereA.Gutierrez-RodríguezM.GaraigortaU.SolanoR.et al. (2021). SARS-CoV-2 fears green: the chlorophyll catabolite Pheophorbide A is a potent antiviral. Pharmaceuticals14:1048. doi: 10.3390/ph14101048
72
JoS.KimS.ShinD. H.KimM.-S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem.35, 145–151. doi: 10.1080/14756366.2019.1690480
73
JooY.-H.LeeY.-G.LimY.JeonH.LeeI.-G.ChoY.-B.et al. (2022). Anti-influenza A virus activity by Agrimonia pilosa and Galla rhois extract mixture. Biomed. Pharmacother.155:113773. doi: 10.1016/j.biopha.2022.113773
74
KaiH.ObuchiM.YoshidaH.WatanabeW.TsutsumiS.ParkY. K.et al. (2014). In vitro and in vivo anti-influenza virus activities of flavonoids and related compounds as components of Brazilian propolis (AF-08). J. Funct. Foods8, 214–223. doi: 10.1016/j.jff.2014.03.019
75
KannanoorM.LakshmiB. A.KimS. (2021). Synthesis of silver nanoparticles conjugated with kaempferol and hydrocortisone and an evaluation of their antibacterial effects11, 317. doi: 10.1007/s13205-021-02880-y
76
KarimiE.JaafarH. Z. E.AhmadS. (2011). Phytochemical analysis and antimicrobial activities of Methanolic extracts of leaf, stem and root from different varieties of Labisa pumila Benth. Molecules16, 4438–4450. doi: 10.3390/molecules16064438
77
KaulT. N.MiddletonE.OgraP. L. (1985). Antiviral effect of flavonoids on human viruses. J. Med. Virol.15, 71–79. doi: 10.1002/jmv.1890150110
78
KaulR.PaulP.KumarS.BüsselbergD.DwivediV. D.ChaariA. (2021). Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: systematic review. Int. J. Mol. Sci.22:11069. doi: 10.3390/ijms222011069
79
KhalilA.TazeddinovaD.AljoumaaK.KazhmukhanbetkyzyZ. A.OrazovA.ToshevA. D. (2021). Carotenoids: therapeutic strategy in the Battle against viral emerging diseases, COVID-19: An overview. Prev. Nutr. Food Sci.26, 241–261. doi: 10.3746/pnf.2021.26.3.241
80
KimH. J.WooE.-R.ShinC.-G.ParkH. (1998). A new Flavonol glycoside Gallate Ester from Acer okamotoanum and its inhibitory activity against Human immunodeficiency Virus-1 (HIV-1) integrase. J. Nat. Prod.61, 145–148. doi: 10.1021/np970171q
81
KnippingK.GarssenJ.van’t LandB. (2012). An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol. J.9:137. doi: 10.1186/1743-422X-9-137
82
KwonY.-I.ApostolidisE.LabbeR. G.ShettyK. (2007). Inhibition of Staphylococcus aureus by phenolic phytochemicals of selected clonal herbs species of Lamiaceae Family and likely mode of action through Proline oxidation. Food Biotechnol.21, 71–89. doi: 10.1080/08905430701191205
83
La CameraE.BisignanoC.CrisafiG.SmeriglioA.DenaroM.TrombettaD.et al. (2018). Biochemical characterization of clinical strains of Staphylococcus spp. and their sensitivity to polyphenols-rich extracts from pistachio (Pistacia vera L.). Pathogens7:82. doi: 10.3390/pathogens7040082
84
LacombeA.TadepalliS.HwangC.-A.WuV. C. H. (2013). Phytochemicals in lowbush wild blueberry inactivate Escherichia coli O157:H7 by damaging its cell membrane. Foodborne Pathog. Dis.10, 944–950. doi: 10.1089/fpd.2013.1504
85
LalouckovaK.MalaL.MarsikP.SkrivanovaE. (2021). In vitro antibacterial effect of the Methanolic extract of the Korean soybean fermented product Doenjang against Staphylococcus aureus. Animals11:2319. doi: 10.3390/ani11082319
86
LambertR. J. W.SkandamisP. N.CooteP. J.NychasG.-J. E. (2001). A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol.91, 453–462. doi: 10.1046/j.1365-2672.2001.01428.x
87
LeCherJ. C.DiepN.KrugP. W.HilliardJ. K. (2019). Genistein has antiviral activity against herpes B virus and acts synergistically with antiviral treatments to reduce effective dose. Viruses11:499. doi: 10.3390/v11060499
88
LechnerD.GibbonsS.BucarF. (2008). Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J. Antimicrob. Chemother.62, 345–348. doi: 10.1093/jac/dkn178
89
LeeI.-K.HwangB.KimD.-W.KimJ.-Y.WooE.-E.LeeY.-J.et al. (2016). Characterization of neuraminidase inhibitors in Korean Papaver rhoeas bee pollen contributing to anti-influenza activities in vitro. Planta Med.82, 524–529. doi: 10.1055/s-0041-111631
90
LeeJ.LeeD. G. (2015). Novel antifungal mechanism of resveratrol: apoptosis inducer in Candida albicans. Curr. Microbiol.70, 383–389. doi: 10.1007/s00284-014-0734-1
91
LeeI.-G.LeeJ.HongS.-H.SeoY.-J. (2023). Apigenin’s therapeutic potential against viral infection. Front. Biosci Landmark28:237. doi: 10.31083/j.fbl2810237
92
LinR.-D.ChinY.-P.HouW.-C.LeeM.-H. (2008). The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA). Planta Med.74, 840–846. doi: 10.1055/s-2008-1074559
93
LinY. T.KwonY. I.LabbeR. G.ShettyK. (2005). Inhibition of helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies. Appl. Environ. Microbiol.71, 8558–8564. doi: 10.1128/AEM.71.12.8558-8564.2005
94
LiuA.-L.LiuB.QinH.-L.LeeS.WangY.-T.DuG.-H. (2008). Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med.74, 847–851. doi: 10.1055/s-2008-1074558
95
LiuT.ZangN.ZhouN.LiW.XieX.DengY.et al. (2014). Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and Armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection. J. Virol.88, 4229–4236. doi: 10.1128/JVI.03637-13
96
LiuZ.ZhaoJ.LiW.ShenL.HuangS.TangJ.et al. (2016). Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Sci. Rep.6:19095. doi: 10.1038/srep19095
97
LuP.ZhangT.RenY.RaoH.LeiJ.ZhaoG.et al. (2023). A literature review on the antiviral mechanism of Luteolin. Nat. Prod. Commun.18:1934578X2311715. doi: 10.1177/1934578X231171521
98
LvX.QiuM.ChenD.ZhengN.JinY.WuZ. (2014). Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir. Res.109, 30–41. doi: 10.1016/j.antiviral.2014.06.004
99
LyuS.-Y.RhimJ.-Y.ParkW.-B. (2005). Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch. Pharm. Res.28, 1293–1301. doi: 10.1007/BF02978215
100
MaY.DingS.FeiY.LiuG.JangH.FangJ. (2019). Antimicrobial activity of anthocyanins and catechins against foodborne pathogens Escherichia coli and Salmonella. Food Control106:106712. doi: 10.1016/j.foodcont.2019.106712
101
MaestriD. (2023). Groundnut and tree nuts: a comprehensive review on their lipid components, phytochemicals, and nutraceutical properties. Crit. Rev. Food Sci. Nutr.1–25, 1–25. doi: 10.1080/10408398.2023.2185202
102
MagiG.MariniE.BrencianiA.Di LodovicoS.GentileD.RubertoG.et al. (2018). Chemical composition of Pistacia vera L. oleoresin and its antibacterial, anti-virulence and anti-biofilm activities against oral streptococci, including Streptococcus mutans. Arch. Oral Biol.96, 208–215. doi: 10.1016/j.archoralbio.2018.09.013
103
MakobongoM. O.GilbreathJ. J.MerrellD. S. (2014). Nontraditional therapies to treat Helicobacter pylori infection. J. Microbiol.52, 259–272. doi: 10.1007/s12275-014-3603-5
104
MandalS. M.DiasR. O.FrancoO. L. (2017). Phenolic compounds in antimicrobial therapy. J. Med. Food20, 1031–1038. doi: 10.1089/jmf.2017.0017
105
MandalariG.BarrecaD.GervasiT.RoussellM. A.KleinB.FeeneyM. J.et al. (2021). Pistachio nuts (Pistacia vera L.): production, nutrients, bioactives and novel health effects. Plants11:18. doi: 10.3390/plants11010018
106
MandalariG.BennettR. N.BisignanoG.TrombettaD.SaijaA.FauldsC. B.et al. (2007). Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J. Appl. Microbiol.103, 2056–2064. doi: 10.1111/j.1365-2672.2007.03456.x
107
MandalariG.BisignanoC.D’ArrigoM.GinestraG.ArenaA.TomainoA.et al. (2010). Antimicrobial potential of polyphenols extracted from almond skins. Lett. Appl. Microbiol.51, 83–89. doi: 10.1111/j.1472-765X.2010.02862.x
108
MandalariG.MinutiA.La CameraE.BarrecaD.RomeoO.NostroA. (2023). Antimicrobial susceptibility of Staphylococcus aureus strains and effect of Phloretin on biofilm formation. Curr. Microbiol.80:303. doi: 10.1007/s00284-023-03400-2
109
ManvarD.MishraM.KumarS.PandeyV. N. (2012). Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba. J. Ethnopharmacol.144, 545–554. doi: 10.1016/j.jep.2012.09.036
110
MartiniN. D.KaterereD. R. P.EloffJ. N. (2004). Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae). J. Ethnopharmacol.93, 207–212. doi: 10.1016/j.jep.2004.02.030
111
MastromarinoP.CapobiancoD.CannataF.NardisC.MattiaE.De LeoA.et al. (2015). Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia. Antivir. Res.123, 15–21. doi: 10.1016/j.antiviral.2015.08.010
112
MazzonM.JonesM.DavidsonA.ChainB.JacobsM. (2009). Dengue virus NS5 inhibits interferon-α signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J. Infect. Dis.200, 1261–1270. doi: 10.1086/605847
113
MerchatM.BertoliniG.GiacominiP.VillaneuvaA.JoriG. (1996). Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J. Photochem. Photobiol. B32, 153–157. doi: 10.1016/1011-1344(95)07147-4
114
MinnockA.VernonD. I.SchofieldJ.GriffithsJ.Howard ParishJ.BrownS. B. (1996). Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J. Photochem. Photobiol. B32, 159–164. doi: 10.1016/1011-1344(95)07148-2
115
MitraS.RaufA.TareqA. M.JahanS.EmranT. B.ShahriarT. G.et al. (2021). Potential health benefits of carotenoid lutein: An updated review. Food Chem. Toxicol.154:112328. doi: 10.1016/j.fct.2021.112328
116
Mohammadi PourP.FakhriS.AsgaryS.FarzaeiM. H.EcheverríaJ. (2019). The signaling pathways, and therapeutic targets of antiviral agents: focusing on the antiviral approaches and clinical perspectives of Anthocyanins in the Management of Viral Diseases. Front. Pharmacol.10:485177. doi: 10.3389/fphar.2019.01207
117
MorimotoR.HanadaA.MatsubaraC.HorioY.SumitaniH.OgataT.et al. (2023). Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship. J. Nat. Med.77, 219–227. doi: 10.1007/s11418-022-01660-z
118
MurrayC. J. L.IkutaK. S.ShararaF.SwetschinskiL.Robles AguilarG.GrayA.et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet399, 629–655. doi: 10.1016/S0140-6736(21)02724-0
119
MurtazaG.KarimS.AkramM. R.KhanS. A.AzharS.MumtazA.et al. (2014). Caffeic acid Phenethyl Ester and Therapeutic potentials. Biomed. Res. Int.2014, 1–9. doi: 10.1155/2014/145342
120
Musarra-PizzoM.GinestraG.SmeriglioA.PennisiR.SciortinoM. T.MandalariG. (2019). The antimicrobial and antiviral activity of polyphenols from almond (Prunus dulcis L.) skin. Nutrients11:2355. doi: 10.3390/nu11102355
121
Musarra-PizzoM.PennisiR.Ben-AmorI.SmeriglioA.MandalariG.SciortinoM. T. (2020). In vitro anti-HSV-1 activity of polyphenol-rich extracts and pure polyphenol compounds derived from pistachios kernels (Pistacia vera L.). Plan. Theory9:267. doi: 10.3390/plants9020267
122
NazS.SiddiqiR.AhmadS.RasoolS. A.SayeedS. A. (2007). Antibacterial activity directed isolation of compounds from Punica granatum. J. Food Sci.72, M341–M345. doi: 10.1111/j.1750-3841.2007.00533.x
123
NeveuV.Perez-JimenezJ.VosF.CrespyV.du ChaffautL.MennenL.et al. (2010). Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database2010:bap024. doi: 10.1093/database/bap024
124
NguyenT. L. A.BhattacharyaD. (2022). Antimicrobial activity of quercetin: An approach to its mechanistic principle. Molecules27:2494. doi: 10.3390/molecules27082494
125
NguyenT.-T.KethaA.HieuH. V.TatipamulaV. B. (2021). In vitro antimycobacterial studies of flavonols from Bauhinia vahlii Wight and Arn11, 128. doi: 10.1007/s13205-021-02672-4
126
NiemenakN.RohsiusC.ElwersS.Omokolo NdoumouD.LiebereiR. (2006). Comparative study of different cocoa (Theobroma cacao L.) clones in terms of their phenolics and anthocyanins contents. J. Food Compos. Anal.19, 612–619. doi: 10.1016/j.jfca.2005.02.006
127
Nikolaeva-GlombL.MukovaL.NikolovaN.BadjakovI.DinchevaI.KondakovaV.et al. (2014). In vitro antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-, Orthomyxo - and Paramyxoviridae. Nat. Prod. Commun.9:1934578X1400900. doi: 10.1177/1934578X1400900116
128
OhnoM.ShibataC.KishikawaT.YoshikawaT.TakataA.KojimaK.et al. (2013). The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Sci. Rep.3:2553. doi: 10.1038/srep02553
129
ÖzçelikB.AslanM.OrhanI.KaraogluT. (2005). Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera. Microbiol. Res.160, 159–164. doi: 10.1016/j.micres.2004.11.002
130
ÖzçelikB.KartalM.OrhanI. (2011). Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm. Biol.49, 396–402. doi: 10.3109/13880209.2010.519390
131
ÖzçelikB.OrhanI.TokerG. (2006). Antiviral and antimicrobial assessment of some selected flavonoids. Zeitschrift für Naturforschung C61, 632–638. doi: 10.1515/znc-2006-9-1003
132
PangR.TaoJ.ZhangS.ZhaoL.YueX.WangY.et al. (2010). In vitro antiviral activity of lutein against hepatitis B virus. Phytother. Res.24, 1627–1630. doi: 10.1002/ptr.3155
133
PauloL.FerreiraS.GallardoE.QueirozJ. A.DominguesF. (2010). Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J. Microbiol. Biotechnol.26, 1533–1538. doi: 10.1007/s11274-010-0325-7
134
PennisiR.TrischittaP.TamburelloM. P.BarrecaD.MandalariG.SciortinoM. T. (2023). Mechanistic understanding of the antiviral properties of pistachios and Zeaxanthin against HSV-1. Viruses15:1651. doi: 10.3390/v15081651
135
PeriferakisA.PeriferakisK.BadarauI. A.PetranE. M.PopaD. C.CaruntuA.et al. (2022). Kaempferol: antimicrobial properties, sources, clinical, and traditional applications. Int. J. Mol. Sci.23:15054. doi: 10.3390/ijms232315054
136
PetreraE.NíttoloA. G.AlchéL. E. (2014). Antiviral action of synthetic stigmasterol derivatives on herpes simplex virus replication in nervous cells in vitro. Biomed. Res. Int.2014:947560. doi: 10.1155/2014/947560
137
Pierre LuhataL.UsukiT. (2021). Antibacterial activity of β-sitosterol isolated from the leaves of Odontonema strictum (Acanthaceae). Bioorg. Med. Chem. Lett.48:128248. doi: 10.1016/j.bmcl.2021.128248
138
Pisonero-VaqueroS.García-MediavillaM. V.JorqueraF.MajanoP. L.BenetM.JoverR.et al. (2014). Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin. Lab. Investig.94, 262–274. doi: 10.1038/labinvest.2013.156
139
PojerE.MattiviF.JohnsonD.StockleyC. S. (2013). The case for anthocyanin consumption to promote Human health: A review. Compr. Rev. Food Sci. Food Saf.12, 483–508. doi: 10.1111/1541-4337.12024
140
PourghanbariG.NiliH.MoattariA.MohammadiA.IrajiA. (2016). Antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2). Virus Disease27, 170–178. doi: 10.1007/s13337-016-0321-0
141
QasimiM.AzizI.RasheedM.GuliB.KhanM. A. (2016). Effect of extraction solvents on polyphenols and antioxidant activity on medicinal halophytes. Pak. J. Bot.48, 621–627.
142
QianW.LiuM.FuY.ZhangJ.LiuW.LiJ.et al. (2020). Antimicrobial mechanism of luteolin against Staphylococcus aureus and listeria monocytogenes and its antibiofilm properties. Microb. Pathog.142:104056. doi: 10.1016/j.micpath.2020.104056
143
RaviL.GirishS.HarshiniM.SreenivasB. K. A. (2020). β-Sitosterol: an antibacterial agent in aquaculture Management of Vibrio Infections. J. Pure Appl. Microbiol.14, 2699–2714. doi: 10.22207/JPAM.14.4.48
144
ReygaertW. C. (2014). The antimicrobial possibilities of green tea. Front. Microbiol.5:434. doi: 10.3389/fmicb.2014.00434
145
RittàM.MarengoA.CivraA.LemboD.CaglieroC.KantK.et al. (2020). Antiviral activity of a Arisaema Tortuosum leaf extract and some of its constituents against herpes simplex virus type 2. Planta Med.86, 267–275. doi: 10.1055/a-1087-8303
146
RofealM.El-MalekF. A.QiX. (2021). In vitro assessment of green polyhydroxybutyrate/chitosan blend loaded with kaempferol nanocrystals as a potential dressing for infected wounds. Nanotechnology32:375102. doi: 10.1088/1361-6528/abf7ee
147
RojasÁ.Del CampoJ. A.ClementS.LemassonM.García-ValdecasasM.Gil-GómezA.et al. (2016). Effect of quercetin on hepatitis C virus life cycle: from viral to host targets. Sci. Rep.6:31777. doi: 10.1038/srep31777
148
RyuY. B.JeongH. J.KimJ. H.KimY. M.ParkJ.-Y.KimD.et al. (2010). Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg. Med. Chem.18, 7940–7947. doi: 10.1016/j.bmc.2010.09.035
149
SantiagoC.PangE. L.LimK.-H.LohH.-S.TingK. N. (2015). Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of ampicillin and a bioactive fraction from Duabanga grandiflora. BMC Complement. Altern. Med.15:178. doi: 10.1186/s12906-015-0699-z
150
SeeramN.ZhangY.BowermanS.HeberD. (2008). Phytochemicals and health aspects of pistachio (Pistacia vera L.). Tree Nuts. CRC Press.309–318. doi: 10.1201/9781420019391.ch18
151
SekerG.AkbasM. Y. (2023). Evaluation of bioactivities of Pistacia vera L. hull extracts as a potential antimicrobial and antioxidant natural source. Food Sci. Technol. Int. doi: 10.1177/10820132231193478
152
ShahdadiF.KhorasaniS.Salehi-SardoeiA.FallahnajmabadiF.Fazeli-NasabB.SayyedR. Z. (2023). GC-MS profiling of pistachio vera L., and effect of antioxidant and antimicrobial compounds of it’s essential oil compared to chemical counterparts. Sci. Rep.13:21694. doi: 10.1038/s41598-023-48844-5
153
ShettyK.WahlqvistM. L. (2004). A model for the role of the proline-linked pentose-phosphate pathway in phenolic phytochemical bio-synthesis and mechanism of action for human health and environmental applications. Asia Pac. J. Clin. Nutr.13, 1–24
154
ShibataC.OhnoM.OtsukaM.KishikawaT.GotoK.MuroyamaR.et al. (2014). The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. Virology462-463, 42–48. doi: 10.1016/j.virol.2014.05.024
155
ShihS.-R.StollarV.LiM.-L. (2011). Host factors in enterovirus 71 replication. J. Virol.85, 9658–9666. doi: 10.1128/JVI.05063-11
156
SimõesC. M. O.ReginattoF. H.CalveteE. O.HenriqueC.da SilvaB.CarvalhoA. (2012). Anti HSV-1 activity of five strawberry cultivars. Lat. Am. J. Pharm.
157
SinghB. N.UpretiD. K.SinghB. R.PandeyG.VermaS.RoyS.et al. (2015). Quercetin sensitizes fluconazole-resistant Candida albicans to induce apoptotic cell death by modulating quorum sensing. Antimicrob. Agents Chemother.59, 2153–2168. doi: 10.1128/AAC.03599-14
158
SmeriglioA.DenaroM.BarrecaD.CalderaroA.BisignanoC.GinestraG.et al. (2017). In vitro evaluation of the antioxidant, Cytoprotective, and antimicrobial properties of essential oil from Pistacia vera L. variety Bronte Hull. Int. J. Mol. Sci.18:1212. doi: 10.3390/ijms18061212
159
SuvorovN.PogorilyyV.DiachkovaE.Vasil’evY.MironovA.GrinM. (2021). Derivatives of natural chlorophylls as agents for antimicrobial photodynamic therapy. Int. J. Mol. Sci.22:6392. doi: 10.3390/ijms22126392
160
TaghizadehS. F.RezaeeR.MehmandoustM.BadibostanH.KarimiG. (2020). Assessment of in vitro bioactivities of Pis v 1 (2S albumin) and Pis v 2.0101 (11S globulin) proteins derived from pistachio (Pistacia vera L.). Food Measure14, 1054–1063. doi: 10.1007/s11694-019-00355-6
161
TaylorP. W.Hamilton-MillerJ. M. T.StapletonP. D. (2005). Antimicrobial properties of green tea catechins. Food Sci. Technol. Bullet.2, 71–81. doi: 10.1616/1476-2137.14184
162
TokuşogluO.UnalM. K.YemişF. (2005). Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J. Agric. Food Chem.53, 5003–5009. doi: 10.1021/jf050496+
163
TomainoA.MartoranaM.ArcoraciT.MonteleoneD.GiovinazzoC.SaijaA. (2010). Antioxidant activity and phenolic profile of pistachio (Pistacia vera L., variety Bronte) seeds and skins. Biochimie92, 1115–1122. doi: 10.1016/j.biochi.2010.03.027
164
ToujaniM. M.RittàM.CivraA.GenoveseS.EpifanoF.GhramA.et al. (2018). Inhibition of HSV-2 infection by pure compounds from Thymus capitatus extract in vitro. PTR32, 1555–1563. doi: 10.1002/ptr.6084
165
UlanowskaK.TkaczykA.KonopaG.WęgrzynG. (2006). Differential antibacterial activity of genistein arising from global inhibition of DNA, RNA and protein synthesis in some bacterial strains. Arch. Microbiol.184, 271–278. doi: 10.1007/s00203-005-0063-7
166
UlusoyS.Boşgelmez-TınazG.Seçilmiş-CanbayH. (2009). Tocopherol, carotene, phenolic contents and antibacterial properties of rose essential oil, hydrosol and absolute. Curr. Microbiol.59, 554–558. doi: 10.1007/s00284-009-9475-y
167
VelaE. M.KnostmanK. A.MottJ. M.WarrenR. L.GarverJ. N.VelaL. J.et al. (2010). Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model. Antivir. Res.87, 318–328. doi: 10.1016/j.antiviral.2010.06.007
168
VestergaardM.IngmerH. (2019). Antibacterial and antifungal properties of resveratrol. Int. J. Antimicrob. Agents53, 716–723. doi: 10.1016/j.ijantimicag.2019.02.015
169
Visintini JaimeM. F.RedkoF.MuschiettiL. V.CamposR. H.MartinoV. S.CavallaroL. V. (2013). In vitro antiviral activity of plant extracts from Asteraceae medicinal plants. Virol. J.10:245. doi: 10.1186/1743-422X-10-245
170
WangM.FirrmanJ.LiuL.YamK. (2019). A review on flavonoid Apigenin: dietary intake, ADME, antimicrobial effects, and interactions with Human gut microbiota. Biomed. Res. Int.2019, 1–18. doi: 10.1155/2019/7010467
171
WangY.LiF.WangZ.SongX.RenZ.WangX.et al. (2023). Luteolin inhibits herpes simplex virus 1 infection by activating cyclic guanosine monophosphate-adenosine monophosphate synthase-mediated antiviral innate immunity. Phytomedicine120:155020. doi: 10.1016/j.phymed.2023.155020
172
WangS.LingY.YaoY.ZhengG.ChenW. (2020). Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway. Virol. J.17:187. doi: 10.1186/s12985-020-01451-6
173
WangL.-H.WangM.-S.ZengX.-A.XuX.-M.BrennanC. S. (2017). Membrane and genomic DNA dual-targeting of citrus flavonoid naringenin against Staphylococcus aureus. Integr. Biol.9, 820–829. doi: 10.1039/C7IB00095B
174
XuL.JiangW.JiaH.ZhengL.XingJ.LiuA.et al. (2020a). Discovery of multitarget-directed ligands against influenza virus from compound Yizhihao through a predictive system for compound-protein interactions. Front. Cell. Infect. Microbiol.10:17. doi: 10.3389/fcimb.2020.00016
175
XuX.MiaoJ.ShaoQ.GaoY.HongL. (2020b). Apigenin suppresses influenza A virus-induced RIG-I activation and viral replication. J. Med. Virol.92, 3057–3066. doi: 10.1002/jmv.26403
176
XuL.SuW.JinJ.ChenJ.LiX.ZhangX.et al. (2014). Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses6, 2778–2795. doi: 10.3390/v6072778
177
YangJ.LiuR. H.HalimL. (2009). Antioxidant and antiproliferative activities of common edible nut seeds. LWT-Food Sci. Technol.42, 1–8. doi: 10.1016/j.lwt.2008.07.007
178
YiL.LiZ.YuanK.QuX.ChenJ.WangG.et al. (2004). Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol.78, 11334–11339. doi: 10.1128/jvi.78.20.11334-11339.2004
179
YimS.-K.KimI.WarrenB.KimJ.JungK.KuB. (2021). Antiviral activity of two marine carotenoids against SARS-CoV-2 virus entry in Silico and in vitro. Int. J. Mol. Sci.22:6481. doi: 10.3390/ijms22126481
180
YinJ.PengX.LinJ.ZhangY.ZhangJ.GaoH.et al. (2021). Quercetin ameliorates Aspergillus fumigatus keratitis by inhibiting fungal growth, toll-like receptors and inflammatory cytokines. Int. Immunopharmacol.93:107435. doi: 10.1016/j.intimp.2021.107435
181
YoussefF. S.AltyarA. E.OmarA. M.AshourM. L. (2021). Phytoconstituents, in vitro anti-infective activity of Buddleja indica lam., and in Silico evaluation of its SARS-CoV-2 inhibitory potential. Front. Pharmacol.12:619373. doi: 10.3389/fphar.2021.619373
182
YucharoenR. (2011). Inhibitory effect of aromatic herbs, lavender, sage and chamomile against herpes simplex virus infection. Afr. J. Biotechnol.10, 15394–1401. doi: 10.5897/AJB11.2393
183
YusufA. J.AbdullahiM. I.AlekuG. A.IbrahimI. A. A.AlebiosuC. O.YahayaM.et al. (2018). Antimicrobial activity of stigmasterol from the stem bark of Neocarya macrophylla. J. Med. Plants Econom. Dev.2, 1–5. doi: 10.4102/jomped.v2i1.38
184
ZhangL.LinD.SunX.CurthU.DrostenC.SauerheringL.et al. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science368, 409–412. doi: 10.1126/science.abb3405
185
ZhangW.QiaoH.LvY.WangJ.ChenX.HouY.et al. (2014). Apigenin inhibits Enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS One 9:e110429. doi: 10.1371/journal.pone.0110429
Summary
Keywords
pistachio, bioactive compounds, antimicrobial effect, antivirals, mechanism of action
Citation
Mandalari G, Pennisi R, Gervasi T and Sciortino MT (2024) Pistacia vera L. as natural source against antimicrobial and antiviral resistance. Front. Microbiol. 15:1396514. doi: 10.3389/fmicb.2024.1396514
Received
05 March 2024
Accepted
10 June 2024
Published
01 July 2024
Volume
15 - 2024
Edited by
Zengfeng Zhang, Shanghai Jiao Tong University, China
Reviewed by
Giorgio Gribaudo, University of Turin, Italy
Qinchang Zhu, Shenzhen Technology University, China
Updates
Copyright
© 2024 Mandalari, Pennisi, Gervasi and Sciortino.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Giuseppina Mandalari, giuseppina.mandalari@unime.itRosamaria Pennisi, rosamaria.pennisi@unime.it
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.